Report: Drug delivery investments down in Q3

Investment spending in the drug delivery sector has dropped significantly for the third quarter, but is staying ahead of last years numbers for the first through third quarters, according to a new report.
Venture capital investments fell a significant 61.8% to $29.6 million during the three months ended September 30, though deal volume stayed the same when compared to the third quarter of 2017, according to the MoneyTree report from PricewaterhouseCoopers and CB Insight.
Read the whole story on our sister site, Drug Delivery Business News
The post Report: Drug delivery investments down in Q3 appeared first on MassDevice.

Source: Mass Device - October 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Wall Street Beat CB Insights PricewaterhouseCoopers (PwC) Venture Capital/Private Equity Source Type: news